Axa
BMY icon

Axa’s Bristol-Myers Squibb BMY Stock Holding History

Axa’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,746,873
Closed -$127M – 213
2025
Q2 		$127M Buy
2,746,873
+887,532
+48% +$43.6M 0.37% 54
2025
Q1 		$113M Sell
1,859,341
-172,853
-9% -$10.1M 0.37% 59
2024
Q4 		$115M Buy
2,032,194
+900,240
+80% +$50.3M 0.35% 56
2024
Q3 		$58.6M Sell
1,131,954
-144,650
-11% -$6.79M 0.17% 125
2024
Q2 		$53M Sell
1,276,604
-1,239,833
-49% -$55.5M 0.16% 134
2024
Q1 		$136M Buy
2,516,437
+155,632
+7% +$7.93M 0.41% 52
2023
Q4 		$121M Sell
2,360,805
-89,468
-4% -$4.7M 0.39% 57
2023
Q3 		$142M Buy
2,450,273
+279,415
+13% +$17.1M 0.5% 39
2023
Q2 		$139M Sell
2,170,858
-304,028
-12% -$20.4M 0.46% 42
2023
Q1 		$172M Buy
2,474,886
+92,110
+4% +$6.5M 0.59% 30
2022
Q4 		$171M Buy
2,382,776
+251,361
+12% +$19M 0.62% 25
2022
Q3 		$152M Buy
2,131,415
+744,610
+54% +$54M 0.6% 23
2022
Q2 		$107M Sell
1,386,805
-200,150
-13% -$15.2M 0.4% 57
2022
Q1 		$116M Buy
1,586,955
+85,650
+6% +$5.75M 0.33% 72
2021
Q4 		$93.6M Buy
1,501,305
+205,642
+16% +$12.1M 0.24% 105
2021
Q3 		$76.7M Buy
1,295,663
+857,271
+196% +$56.5M 0.22% 113
2021
Q2 		$29.3M Sell
438,392
-8,907
-2% -$581K 0.08% 279
2021
Q1 		$28.2M Buy
447,299
+66,575
+17% +$4.14M 0.09% 274
2020
Q4 		$23.6M Sell
380,724
-36,805
-9% -$2.26M 0.07% 295
2020
Q3 		$25.2M Sell
417,529
-133,789
-24% -$8.05M 0.09% 250
2020
Q2 		$32.4M Sell
551,318
-357,718
-39% -$21.4M 0.13% 191
2020
Q1 		$50.7M Sell
909,036
-460,965
-34% -$28.2M 0.25% 99
2019
Q4 		$87.9M Sell
1,370,001
-82,493
-6% -$4.72M 0.36% 62
2019
Q3 		$73.7M Sell
1,452,494
-3,881
-0.3% -$182K 0.29% 85
2019
Q2 		$66M Buy
1,456,375
+3,427
+0.2% +$160K 0.26% 101
2019
Q1 		$69.3M Buy
1,452,948
+96,464
+7% +$4.81M 0.27% 104
2018
Q4 		$70.5M Buy
1,356,484
+1,102,073
+433% +$59.2M 0.31% 86
2018
Q3 		$15.8M Sell
254,411
-1,558
-0.6% -$92.5K 0.06% 358
2018
Q2 		$14.2M Sell
255,969
-63,547
-20% -$3.43M 0.05% 352
2018
Q1 		$20.2M Sell
319,516
-52,070
-14% -$3.35M 0.08% 285
2017
Q4 		$22.8M Buy
371,586
+79,444
+27% +$4.97M 0.09% 267
2017
Q3 		$18.6M Sell
292,142
-105,289
-26% -$6.15M 0.08% 286
2017
Q2 		$22.1M Sell
397,431
-166,355
-30% -$9.05M 0.1% 242
2017
Q1 		$30.7M Buy
563,786
+125,583
+29% +$6.89M 0.14% 205
2016
Q4 		$25.6M Sell
438,203
-107,570
-20% -$5.88M 0.12% 213
2016
Q3 		$29.4M Sell
545,773
-181,781
-25% -$11.7M 0.13% 207
2016
Q2 		$53.5M Buy
727,554
+295,306
+68% +$20.9M 0.24% 121
2016
Q1 		$27.6M Sell
432,248
-139,936
-24% -$8.82M 0.12% 214
2015
Q4 		$39.4M Sell
572,184
-3,853
-0.7% -$255K 0.17% 173
2015
Q3 		$34.1M Sell
576,037
-221,602
-28% -$14.1M 0.14% 185
2015
Q2 		$53.1M Buy
797,639
+125,991
+19% +$8.3M 0.21% 139
2015
Q1 		$43.3M Buy
671,648
+90,843
+16% +$5.69M 0.18% 152
2014
Q4 		$34.3M Sell
580,805
-12,422
-2% -$701K 0.14% 183
2014
Q3 		$30.4M Buy
593,227
+9,714
+2% +$485K 0.13% 203
2014
Q2 		$28.3M Buy
583,513
+22,133
+4% +$1.09M 0.12% 204
2014
Q1 		$29.2M Buy
561,380
+13,641
+2% +$726K 0.13% 195
2013
Q4 		$29.1M Buy
547,739
+88,679
+19% +$4.52M 0.13% 191
2013
Q3 		$21.2M Buy
459,060
+6,950
+2% +$305K 0.1% 223
2013
Q2 		$20.2M Buy
+452,110
New +$19.6M 0.11% 210

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Axa's BMY Position: Q3 2025 in Review

Axa sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 2,746,873 shares — an estimated $127M sold.

Axa first reported a position in BMY in Q2 2013 and held it in 49 quarters. The position peaked at $172M in Q1 2023. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Axa reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Axa sold 2,746,873 Bristol-Myers Squibb shares in Q3 2025, an estimated $127M.
  • Axa first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 49 quarters.
  • Axa's Bristol-Myers Squibb position peaked at $172M in Q1 2023.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.